Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS Foundation, is one of the most comprehensive HIV treatment publications, with hundreds of in-depth articles.

BETA is published quarterly by the San Francisco AIDS Foundation.

BETA
Main page

Subscribe (free)

Contact Us
beta@sfaf.org

Spring 2000 Table of Contents

Features

Letter from the Editor: Old Questions Trouble the New Millennium
HIV Persists Despite HAART
Adverse Effects Associated with Antiretroviral Therapy
Structured Treatment Interruption: Future Protocol or Wishful Thinking?

Special Report on HIV & AIDS

I. HIV is the Only Cause of AIDS: The Potential for Journalism to Impact the Public Health

II. HIV Causes AIDS: Proof Derived from Koch's Postulates

BETA Reader Survey Summary and Pricing Announcement

Departments

BETA News Briefs
Drug Watch
Entry Inhibitors Are Featured at the 7th CROI

Tenofovir DF: A Promising Nucleotide Analog in Development

Women and HIV
Women, Access, and Adherence to HAART: A Vital Connection

Conference Coverage
Selected Highlights from the
7th Conference on Retroviruses and Opportunistic Infections

Open Clinical Trials
Glossary

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Contributors to this issue:

  • Harvey S. Bartnof, MD
  • Nicholas Cheonis
  • Dave Gilden
  • Leslie Hanna
  • Liz Highleyman
  • Valerie Stone, MD, MPH
  • Tim Teeter
  • David Townley
  • Mark Wainberg, PhD

Scientific Advisory Committee:

  • Kirsten Balano, PharmD
  • Harvey S. Bartnof, MD
  • Gregory Pauxtis, MD
  • Mary Romeyn, MD

Page last updated 2 June 2000


About AIDS | Treatment | Prevention | Policy | About SFAF | Take Action | Donate
Espaņol | Search | Site Map | Feedback | Email Updates | Home (sfaf.org)